BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29485440)

  • 1. Gastric Metastasis of Prostate Cancer as an Unusual Presentation Using 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Solis Lara HE; Villarreal Del Bosque N; Sada Treviño MA; Yamamoto Ramos M; Argueta Ruiz RDC
    Clin Nucl Med; 2018 May; 43(5):e156-e159. PubMed ID: 29485440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental Metastatic Melanoma Identified on 68Ga-Prostate-Specific Membrane Antigen PET/CT for Metastatic Prostate Cancer.
    Snow HA; Hofman MS; Mitchell CA; Gyorki DE; Smith MJF
    Clin Nucl Med; 2018 Jul; 43(7):509-511. PubMed ID: 29742609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
    Ergül N; Yilmaz Güneş B; Yücetaş U; Toktaş MG; Çermik TF
    Clin Nucl Med; 2018 Dec; 43(12):e422-e427. PubMed ID: 30273204
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiphasic
    Beheshti M; Manafi-Farid R; Geinitz H; Vali R; Loidl W; Mottaghy FM; Langsteger W
    J Nucl Med; 2020 Oct; 61(10):1484-1490. PubMed ID: 32060214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT With
    Giovacchini G; Giovannini E; Riondato M; Ciarmiello A
    Curr Radiopharm; 2018; 11(1):4-13. PubMed ID: 29090673
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
    J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.
    Demirkol MO; Kiremit MC; Acar O; Ucar B; Saglican Y
    Clin Nucl Med; 2017 May; 42(5):403-405. PubMed ID: 28319496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
    Raju S; Sharma A; Patel C; Sahoo R; Das CJ; Kumar S; Sharma A; Kumar R
    Nucl Med Commun; 2020 Nov; 41(11):1183-1188. PubMed ID: 32796451
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    de Jong AC; Smits M; van Riet J; Fütterer JJ; Brabander T; Hamberg P; van Oort IM; de Wit R; Lolkema MP; Mehra N; Segbers M; van der Veldt AAM
    J Nucl Med; 2020 Nov; 61(11):1607-1614. PubMed ID: 32169916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective correlation of
    Onal C; Torun N; Oymak E; Guler OC; Reyhan M; Yapar AF
    Ann Nucl Med; 2020 Jun; 34(6):388-396. PubMed ID: 32221791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between molecular tumor volume evaluated with
    Medina-Ornelas Sevastián S; García-Pérez Francisco O; Hernández-Pedro Norma Y; Arellano-Zarate Angélica E; Abúndiz-López Blanca L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):223-228. PubMed ID: 29454548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological predictors of positive
    Aydin AM; Haberal B; Artykov M; Bilen CY; Yazici S
    Ann Nucl Med; 2019 May; 33(5):326-332. PubMed ID: 30778860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumbar Osteophyte Avid on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Jochumsen MR; Madsen MA; Gammelgaard L; Bouchelouche K
    Clin Nucl Med; 2018 Jun; 43(6):456-457. PubMed ID: 29538033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-Specific Membrane Antigen-Negative Metastases-A Potential Pitfall in Prostate-Specific Membrane Antigen PET.
    Noto B; Auf der Springe K; Huss S; Allkemper T; Stegger L
    Clin Nucl Med; 2018 Jun; 43(6):e186-e188. PubMed ID: 29659383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer.
    Aydin F; Akçal A; Ünal B; Sezgin Göksu S; Güngör F
    Clin Nucl Med; 2017 May; 42(5):358-360. PubMed ID: 28240656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncommon Penio-Scrotal Metastases of Prostate Cancer Detected on 68Ga PSMA PET/CT.
    Seniaray N; Verma R; Khanna S; Belho E; Malik D
    Clin Nucl Med; 2019 May; 44(5):424-425. PubMed ID: 30829866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.